Healthcare employer burns $1.258M in employee solicitation case, wins $1,627

A healthcare employer spent $1.258 million in legal fees to chase a former executive – and walked away with $1,627.59. 

That was the outcome in a case the Delaware Court of Chancery decided on April 16, 2026. It involved an opioid treatment company with twenty-nine clinics across seven states, a rising executive who opened a competing facility two miles away, and a workforce crisis that may have caused more damage than the alleged betrayal ever did. 

Perla Ramirez-Groothuis started at Colorado Treatment Services, a Maric subsidiary, as a substance abuse counselor in 2016. She climbed quickly – program director, executive director, and eventually regional executive director overseeing clinics in Colorado and New Mexico. She signed operating agreements making her Manager and President of two Maric entities, which carried fiduciary obligations equivalent to those of a corporate officer under Delaware law. 

The trouble started at the CTS Pueblo clinic. Counselor caseloads had ballooned to roughly 80 patients each, far exceeding the company's own target of 55 to 60. The average monthly patient count jumped from 507 in 2021 to 680 in 2022, and by year-end the clinic was serving roughly 700 patients. Staff were stretched thin. Lines wrapped around the facility. The lobby was frequently congested. Frontline employees started leaving, and the front desk eventually began turning patients away. The court described it as a vicious spiral – understaffing led to burnout, which led to more departures, which made everything worse. 

Ramirez asked the company's CEO whether Maric would open a second clinic in Pueblo to handle the overflow. The answer was no. The court found that Maric had not opened a new clinic anywhere since 2019, had shut down three that were in progress, and had no intention of expanding further. 

So, Ramirez took matters into her own hands. She had previously formed Elevate Healthcare in 2021 as a consulting entity, helping other providers establish methadone treatment clinics at the encouragement of Colorado's State Opioid Treatment Authority. While still employed at Maric, Ramirez used that entity to secure a lease, obtain state licensure, and open a competing opioid treatment clinic in Pueblo in March 2023 – two miles from the Maric facility she was managing. 

Maric sued for more than $4 million, alleging that Ramirez usurped a business opportunity, solicited employees, misappropriated trade secrets, and diverted patients. 

The court was unconvinced on nearly every count. 

On the business opportunity claim, the court found that Maric simply could not have opened a second Pueblo clinic – it lacked the financial capacity and had expressly declined the opportunity. The court compared the claim to someone holding an overflowing bucket in a rainstorm and complaining that a person twenty feet away was also holding a bucket and competing for the same rain. 

Maric argued that Ramirez recruited fifteen employees. The court found evidence supporting only one: Ursula Hollins, the CTS Pueblo program director, whom Ramirez hired as Elevate's executive director. The position was never publicly posted, no other candidates applied, and Ramirez interviewed Hollins before receiving her formal application. The court found that sequence hard to explain without prior contact and ruled it a breach of the duty of loyalty. 

As for the other departures, the court concluded that staff left CTS for their own reasons. The workplace was unsustainable, and the record suggested employees were already looking for exits before Elevate existed. The court found that if staff left, it was because the CTS operation – which Ramirez had been working to stabilize – was already sinking on its own. 

The trade secrets claim fizzled. Maric pointed to its internal policies, procedures, and forms, but its own executive testified that those documents were not confidential and had to be shared with the state, accreditation bodies, employees, and patients on request. The tortious interference claim failed for the same reasons the competition claim did – including the fact that Maric could not identify a single patient who left CTS for Elevate. 

The damages case was equally thin. Maric's CFO presented an analysis that assumed every patient who stopped coming to CTS went to Elevate. When asked at trial whether that assumption had any factual basis, she acknowledged it did not. She had never visited the Pueblo clinic, had no direct involvement with CTS operations, and was unaware that Elevate was drawing patients from areas well outside the city. The defense expert from FTI Consulting dismantled the analysis as untethered to the facts and built on unsupported assumptions. 

Maric also asked the court to shift its $1.258 million in legal fees to Ramirez. The court declined, noting that the company had failed to produce a promised damages expert, missed discovery deadlines, and appeared to have scrambled once it became clear that Ramirez intended to go to trial. 

The final tally: Maric won on one narrow claim – the solicitation of a single employee – and was awarded $1,627.59 in mileage reimbursement costs for the replacement hire, plus interest. Ramirez prevailed on everything else. 

For HR professionals, the case raises an obvious question: had Maric put employment-level protections in place – non-competes, non-solicitation clauses, or confidentiality agreements – the outcome may have looked very different. Instead, the company relied solely on fiduciary duty provisions in its corporate agreements. And the case underscores something else HR teams already know: when a workplace becomes unsustainable, no amount of litigation will bring your people back.